reviewAnnual Review of Biomedical EngineeringJul 1, 2010Closed access

Mesenchymal Stem Cells as Therapeutics

Shriners Hospitals for Children - Erie · Harvard University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells that are being clinically explored as a new therapeutic for treating a variety of immune-mediated diseases. First heralded as a regenerative therapy for skeletal tissue repair, MSCs have recently been shown to modulate endogenous tissue and immune cells. Preclinical studies of the mechanism of action suggest that the therapeutic effects afforded by MSC transplantation are short-lived and related to dynamic, paracrine interactions between MSCs and host cells. Therefore, representations of MSCs as drug-loaded particles may allow for pharmacokinetic models to predict the therapeutic activity of MSC transplants as a function of drug delivery mode. By integrating…

Citation impact

767
total citations
FWCI
21.77
Percentile
100%
References
191
Citations per year

Authors

2

Topics & keywords

Keywords
  • Mesenchymal stem cell
  • Stem cell
  • Regenerative medicine
  • Immune system
  • Paracrine signalling
  • Transplantation
  • Clinical uses of mesenchymal stem cells
  • Medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding